Paludisme: un nouveau départ Consulté le 1/02/06 3: Malaria in Africa Consulté le 9110/05 [6] The Global Fund Economie costs of malaria The economic burden of malaria, Consulté le 9110105. [8] Gallup JL, Sachs DJ, pp.85-96, 2001. ,
The economic and social burden of malaria, Nature, vol.415, issue.6872, pp.680-685, 2002. ,
DOI : 10.1038/415680a
The malaria gap, Am J Trop Med Hyg, vol.71, pp.141-146, 2004. ,
Chloroquine???Resistant Malaria, The Journal of Infectious Diseases, vol.184, issue.6, pp.770-776, 2001. ,
DOI : 10.1086/322858
Epidemiology of drug-resistant malaria, The Lancet Infectious Diseases, vol.2, issue.4, pp.209-218, 2002. ,
DOI : 10.1016/S1473-3099(02)00239-6
Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia, The Lancet, vol.360, issue.9326, pp.58-60, 2002. ,
DOI : 10.1016/S0140-6736(02)09336-4
Controlling malaria: challenges and solutions, Tropical Medicine and International Health, vol.55, issue.11, pp.922-927, 2001. ,
DOI : 10.1016/S0140-6736(98)07367-X
Mefloquine-resistant falciparum malaria on the Thai-Burmese border, The Lancet, vol.337, issue.8750, pp.1140-1143, 1991. ,
DOI : 10.1016/0140-6736(91)92798-7
Averting a malaria disaster, The Lancet, vol.353, issue.9168, pp.1965-1967, 1999. ,
DOI : 10.1016/S0140-6736(98)07367-X
Quinine resistant falciparum malaria acquired in east Africa, Trop Med Parasitol, vol.46, pp.38-40, 1995. ,
Antimalarial drug resistance, Journal of Clinical Investigation, vol.113, issue.8, pp.1084-1092, 2004. ,
DOI : 10.1172/JCI21682
Traitement du paludisme : prévenir les résistances par les associations d'antipaludiques, Med Trop, vol.60, pp.219-222, 2000. ,
Antimalarial drug resistance and combination chemotherapy, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.354, issue.1384, pp.739-749, 1999. ,
DOI : 10.1098/rstb.1999.0426
Assessment of the phannacodynamic properties of antimalarial drugs in vivo, AntimicrobAgents Chemother, vol.41, pp.1413-1422, 1997. ,
A model for the origins and spread of drug-resistant malaria, Parasitology, vol.115, issue.2, pp.133-141, 1997. ,
DOI : 10.1017/S0031182097001261
Modelling a Predictable Disaster:, Parasitology Today, vol.16, issue.8, pp.340-347, 2000. ,
DOI : 10.1016/S0169-4758(00)01707-5
Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.96, issue.3, pp.310-317, 2002. ,
DOI : 10.1016/S0035-9203(02)90108-2
Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum?, Parasitology Today, vol.4, issue.4, pp.112-115, 1988. ,
DOI : 10.1016/0169-4758(88)90042-7
The evolution of drug-resistant malaria: the role of drug elimination half-life, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.357, issue.1420, pp.505-519, 2002. ,
DOI : 10.1098/rstb.2001.1036
Combination therapy for malaria in Africa: hype or hope?, Bull World Health Organ, vol.78, pp.1378-1388, 2000. ,
The detection and treatment of Plasmodium falciparum malaria: Time for change, J Postgrad Med, vol.50, pp.35-39, 2004. ,
Epidemiology of drug resistance in malaria, Acta Tropica, vol.56, issue.2-3, pp.143-156, 1994. ,
DOI : 10.1016/0001-706X(94)90060-4
Factors contributing to anemia after uncomplicatedfalciparum malaria, Am J Trop Med Hyg, vol.65, pp.614-622, 2001. ,
The public health impact of chloroquine resistance in Africa, Am J Trop Med Hyg, vol.64, pp.12-17, 2001. ,
Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycaemia, and complications of pregnancy, Am J Trop Med Hyg, vol.64, pp.57-67, 2001. ,
History, Dynamics, and Public Health Importance of Malaria Parasite Resistance, Clinical Microbiology Reviews, vol.17, issue.1, pp.235-254, 2004. ,
DOI : 10.1128/CMR.17.1.235-254.2004
An epidemic of Plasmodium falciparum malaria in Balcad, Somalia, and its causation, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.89, issue.2, pp.142-145, 1995. ,
DOI : 10.1016/0035-9203(95)90469-7
Combination Therapy for Malaria, Drugs, vol.6, issue.11, pp.1315-1329, 2002. ,
DOI : 10.2165/00003495-200262090-00003
Treatment of Chioroquine-Resistant Malaria in African Children: A Cost-Effectiveness Analysis, International Journal of Epidemiology, vol.21, issue.1, pp.146-154, 1992. ,
DOI : 10.1093/ije/21.1.146
Qinghaosu, The Lancet, vol.341, issue.8845, pp.603-608, 1993. ,
DOI : 10.1016/0140-6736(93)90362-K
Une plante chinoise contre le paludisme Le Monde, pp.24-25, 2005. ,
Clinical Pharmacology and Therapeutic Potential of Artemisinin and its Derivatives in the Treatment of Malaria, Drugs, vol.52, issue.6, pp.818-836, 1996. ,
DOI : 10.2165/00003495-199652060-00004
Artemisinin antimalarials: mechanisms of action and resistance, Med Trop, vol.58, pp.13-17, 1998. ,
Données actuelles sur de nouveaux antipaludiques majeurs : les dérivés de l'Artémisinine (Qinghaosu) Bull Acad Natle Med, pp.797-813, 1999. ,
Overview of clinical studies on artemisinin derivatives in Thailand, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.88, issue.1, pp.9-11, 1994. ,
DOI : 10.1016/0035-9203(94)90462-6
A Trial of Artemether or Quinine in Children with Cerebral Malaria, New England Journal of Medicine, vol.335, issue.2, pp.69-75, 1996. ,
DOI : 10.1056/NEJM199607113350201
A Controlled Trial of Artemether or Quinine in Vietnamese Adults with Severe Falciparum Malaria, New England Journal of Medicine, vol.335, issue.2, pp.76-83, 1996. ,
DOI : 10.1056/NEJM199607113350202
Effects of artemisinin derivatives on malaria transmissibility, The Lancet, vol.347, issue.9016, pp.1654-1658, 1996. ,
DOI : 10.1016/S0140-6736(96)91488-9
International Artemisinin Study Group Artesunate combinations for treatment of malaria: metaanalysis, Lance!, vol.363, pp.9-17, 2004. ,
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study, The Lancet, vol.356, issue.9226, pp.297-302, 2000. ,
DOI : 10.1016/S0140-6736(00)02505-8
Artemisinin versus Nonartemisinin Combination Therapy for Uncomplicated Malaria: Randomized Clinical Trials from Four Sites in Uganda, PLoS Medicine, vol.68, issue.7, p.190, 2005. ,
DOI : 10.1371/journal.pmed.0020190.sd002
Effect of Artemether-Lumefantrine Policy and Improved Vector Control on Malaria Burden in KwaZulu???Natal, South Africa, PLoS Medicine, vol.9, issue.11, p.330, 2005. ,
DOI : 10.1371/journal.pmed.0020330.t001
Pharmacokinetics of Artemisinin-Type Compounds, Clinical Pharmacokinetics, vol.40, issue.4, pp.255-270, 2000. ,
DOI : 10.2165/00003088-200039040-00002
The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers, Southeast Asian J Trop Med Public Health, vol.54, issue.35, pp.575-582, 2004. ,
The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria, British Journal of Clinical Pharmacology, vol.43, issue.Suppl 1, pp.23-30, 2002. ,
DOI : 10.1046/j.0306-5251.2001.01519.x
http: //www.dafra.be/fr/products.php . Produits finis de type antipaludique ,
Fichier récapitulatif des différents dérivés de l'artémisinine présents sur le marché africain. Document Sanofi-Aventis/Impact Malaria Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand, Southeast Asian J Trop Med Public Health, vol.34, pp.54-61, 2003. ,
Pharmacokinetics and bioavailability of oral and intramuscular artemether, European Journal of Clinical Pharmacology, vol.52, issue.4, pp.307-338, 1997. ,
DOI : 10.1007/s002280050295
Comparative Pharmacokinetics of Intramuscular Artesunate and Artemether in Patients with Severe Falciparum Malaria, Antimicrobial Agents and Chemotherapy, vol.48, issue.11, pp.4234-4239, 2004. ,
DOI : 10.1128/AAC.48.11.4234-4239.2004
Treatment of African Children with Uncomplicated Falciparum Malaria with a New Antimalarial Drug, CGP 56697, Les associations thérapeutiques à base d 'artémisinine : place dans le traitement du paludisme en Afi"ique (62), pp.1113-1116, 1997. ,
DOI : 10.1086/516524
The rational use of qinghaosu and its derivatives in the treatment of malaria in 1998, Med Trop, vol.58, issue.3, pp.6-8, 1998. ,
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives, Am J Trop Med Hyg, vol.60, issue.65, pp.547-555, 1999. ,
Fatal neurotoxicity of arteether and artemether, Am J Trop Med Hyg, vol.51, pp.251-259, 1994. ,
Studies of the neurotoxicity of oral artemisinin derivatives in mice, Am J Trop Med Hyg, vol.62, pp.409-412, 2000. ,
Artemisinin derivatives in the treatment of falciparum malaria in pregnancy, Trans R Soc Trop Med Hyg, vol.92, pp.430-433, 1998. ,
Delaying antimalarial drug resistance with combination chemotherapy, Parassitologia, vol.41, pp.301-308, 1999. ,
Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 1998. ,
DOI : 10.1016/S1368-7646(98)80208-2
The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria, Fundamental and Clinical Pharmacology, vol.17, issue.2, pp.155-160, 2003. ,
DOI : 10.1046/j.1472-8206.2003.00165.x
Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.91, issue.5, pp.574-577, 1997. ,
DOI : 10.1016/S0035-9203(97)90032-8
Novartis lauches international education program to ensure effective treatment with its fixed dose combination anti-malarial drug product, consisting of artemether and lumefantrine (Coartem®), com . Media realease, 2003. ,
Novaitis renforce les capacité de production de Coartem® pour fournir un médicament susceptible de sauver un plus grand nombre de patients, novartis.com. Communiqué du 22, 2004. ,
A randomized, doubleblind , comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand, Am J Trop Med Hyg, vol.60, pp.238-243, 1999. ,
Randomized comparison of artemetherbenflumetol and artesunate-mefloquine in treatement of multidrug-resistant falciparum malaria, Antimicrob Agents Chemother, vol.42, pp.135-139, 1998. ,
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand, Am J Trop Med Hyg, vol.64, pp.247-256, 2001. ,
Efficacy of six doses of artemetherlumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria, Am J Trop Med Hyg, vol.60, pp.936-942, 1999. ,
Efficacy and safety of CGP 56697 ( artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years, Trop Med Jnt Health, vol.3, pp.498-504, 1998. ,
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicatedfalciparum malaria in African children, Am J Trop Med Hyg, vol.58, pp.638-644, 1998. ,
Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine, Clinical Pharmacokinetics, vol.37, issue.2, pp.105-125, 1999. ,
DOI : 10.2165/00003088-199937020-00002
An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.94, issue.4, pp.419-424, 2000. ,
DOI : 10.1016/S0035-9203(00)90126-3
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine, Am J Trop Med Hyg, vol.61, pp.964-967, 1999. ,
dndi.org/press dossierO l.asp. Press dossier Combination therapy in global strategy for treatment of malaria, 2005. ,
Open randomized study of a1tesunate- amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodiumfalciparum malaria in Nigerian children, Trop Med lnt Health, vol.87, issue.10, pp.1161-1170, 2005. ,
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial, The Lancet, vol.359, issue.9315, pp.1365-1372, 2002. ,
DOI : 10.1016/S0140-6736(02)08348-4
Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.97, issue.3, pp.325-330, 2003. ,
DOI : 10.1016/S0035-9203(03)90161-1
Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria, Tropical Medicine and International Health, vol.1, issue.2, pp.92-98, 2001. ,
DOI : 10.1046/j.1365-3156.1999.00471.x
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial, The Lancet, vol.355, issue.9201, pp.352-357, 2000. ,
DOI : 10.1016/S0140-6736(99)10237-X
Efficacy of two artem1smm combination therapies for uncomplicated falciparum malaria in children under 5 years, p.14 ,
Treatment Of Multidrug-Resistant Plasmodium Falciparum Malaria With 3-Day Artesunate-Mefloquine Combination, Journal of Infectious Diseases, vol.170, issue.4, pp.971-977, 1994. ,
DOI : 10.1093/infdis/170.4.971
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.94, issue.5, pp.537-544, 2000. ,
DOI : 10.1016/S0035-9203(00)90080-4
The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure, Am J Trop Med Hyg, vol.69, pp.19-25, 2003. ,
Efficacy of artesunate plus chloroquine for uncomplicated malaria in children in Sao Tome and Principe: A double-blind, randomized, controlled trial, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.97, issue.6, pp.703-706, 2003. ,
DOI : 10.1016/S0035-9203(03)80107-4
Efficacy and Safety of Dihydroartemisinin???Piperaquine (Artekin) in Cambodian Children and Adults with Uncomplicated Falciparum Malaria, Clinical Infectious Diseases, vol.35, issue.12, pp.1469-1476, 2002. ,
DOI : 10.1086/344647
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial, Lancet, vol.363, pp.18-22, 2004. ,
CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam, Tropical Medicine and International Health, vol.17, issue.2, pp.209-216, 2004. ,
DOI : 10.1098/rstb.1999.0426
Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa, The Lancet, vol.347, issue.8993, pp.24-28, 1996. ,
DOI : 10.1016/S0140-6736(96)91558-5
Developing artemisinin based drug combinations for the treatment of drug resistantfalciparum malaria: A review, J Postgrad Med, vol.50, pp.40-44, 2004. ,
Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa, Trends in Parasitology, vol.19, issue.8, pp.363-369, 2003. ,
DOI : 10.1016/S1471-4922(03)00168-5
Briefing paper: Médicaments antipaludiques en rupture de stock, où sont les responsabilités?, msf.ch : Communiqué du 22 ,
Differences in willingness to pay for artemisinin-based combinations or monotherapy: experience from the United Republic of Tanzania, Bull World Health Organ, vol.83, pp.845-852, 2005. ,
Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa, Tropical Medicine and International Health, vol.363, issue.9, pp.959-966, 2004. ,
DOI : 10.1016/S1471-4922(02)02373-5
Influence of blister packaging on the efficacy of artesunate+mefloquine over artesunate alone in community-based treatment of nonsevere falciparum malaria in Myanmar, Bull World Health Organ, vol.76, issue.1, pp.35-41, 1998. ,
Treatment seeking for malaria: A review of recent research, Social Science & Medicine, vol.43, issue.6, pp.933-945, 1996. ,
DOI : 10.1016/0277-9536(95)00446-7
Malaria morbidity, treatment-seeking behaviour, and mortality in a cohort of young children in rural Burkina Faso, Tropical Medicine and International Health, vol.94, issue.4, pp.290-296, 2003. ,
DOI : 10.1016/S0277-9536(97)00195-0
Pricing, distribution, and use of antimalarial drugs, Bull World Health Organ, vol.69, pp.349-363, 1991. ,
Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modelling to elucidating policy choices, Am J Trop Med Hyg, vol.71, issue.2, pp.179-186, 2004. ,
Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem®, novartis.com. Media release, 06, p.5 ,
who.int/malaria/docs/newsletterl fr.pdf, Nouvelles RBM, issue.1 ,
Assessment of the incidence of substandard drugs in developing countries, Tropical Medicine and International Health, vol.2, issue.9, pp.839-845, 1997. ,
DOI : 10.1046/j.1365-3156.1997.d01-403.x
Fake artesunate in southeast Asia, The Lancet, vol.357, issue.9272, pp.1948-1950, 2001. ,
DOI : 10.1016/S0140-6736(00)05085-6